Indo-MIM IPO: Hold or sell after 35-40% pop?

Indo-MIM IPO: why the hold vs sell debate is trending

Indo-MIM’s IPO is being discussed heavily on social media because the unofficial grey market premium (GMP) is pointing to a potential 34% to 40% listing gain. Retail investors are broadly split into two camps. One group wants to book gains on listing, especially if the stock opens sharply higher. The other group is considering holding, citing the scale of demand signals seen so far. The debate has also intensified because a large part of the offer is an offer for sale (OFS), which affects how investors interpret the IPO proceeds. Alongside GMP chatter, the subscription numbers by category are being tracked intraday. Dates are tight, with allotment expected on July 28 and listing tentatively scheduled for July 30. That leaves limited time for sentiment to shift before listing.

Issue size and structure: fresh issue vs OFS

As per the widely shared IPO details, Indo-MIM’s issue size is about ₹3,811.21 crore. The IPO combines a fresh issue of up to about ₹500 crore and an OFS of up to about ₹3,311.21 crore. Several posts highlight that this means most of the money in the IPO is linked to existing shareholders selling shares. One widely circulated breakdown estimates around 87% of the total offer value is OFS and around 13% is fresh issue capital for the company. This distinction matters in investor conversations because OFS proceeds go to the selling shareholders, not into the company’s cash position. The OFS includes sales by Green Meadows Investments Ltd, Anuradha Koduri, and Indian Institute of Technology Madras, as referenced in multiple summaries. Some longer extracts also list other selling shareholders in draft language shared online, adding to the sense of heavy selling by existing holders. The structure is one reason some investors prefer booking a listing gain rather than holding longer.

Price band, minimum bid, and employee discount

The price band has been fixed at ₹461 to ₹485 per share across reports. Retail investors can apply for a minimum of 30 shares and in multiples of 30 thereafter. At the upper price band, the minimum retail application works out to ₹14,550. An employee discount of ₹45 per share has also been circulated in the shared IPO details. For high net-worth investors, one example minimum bid shown in the summaries is 420 shares for small HNI, translating to ₹2,03,700 at ₹485 per share. These numbers matter in the hold vs sell debate because they shape the absolute rupee gain implied by GMP. For example, if the listing premium is large, the rupee profit per lot becomes a key talking point. At the same time, investors note that none of these figures guarantee the actual listing price.

Subscription trend: what Day 2 numbers showed

Indo-MIM’s IPO was reported as fully subscribed on Day 1, which set the tone for bullish listing expectations online. On Day 2, as of 10:35 AM, the issue was subscribed 1.46 times, as per the shared subscription snapshot. Category data being circulated showed Qualified Institutional Buyers (QIBs) at 0.18x, Non-Institutional Investors (NIIs) at 4.01x, and Retail Individual Investors (RIIs) at 1.09x at that time. This split is central to the listing-day strategy debate. Traders focusing on early momentum point to strong NII demand as a sign of aggressive bidding. More cautious voices note that QIB subscription was still low in the shared Day 2 snapshot. Investors also highlighted that subscription can change materially toward the close, so mid-session figures can be incomplete. Still, these numbers became a key reference point for deciding whether to target a listing pop.

Anchor book: what was disclosed and why it matters

Another major talking point has been the anchor book participation. Posts cite that 92 anchor investors picked up 2.35 crore equity shares worth ₹1,140.99 crore at the upper end of the price band. A detailed excerpt shared online noted that, of the anchor allocation, 1.31 crore equity shares were allotted to 23 domestic mutual funds through 60 schemes. Another widely shared data point says domestic mutual funds received 1.32 crore shares, or 55.98% of the anchor portion, through 60 schemes, while life insurance companies received 22.69 lakh shares, or 9.64% of the anchor allocation. These figures are used in two different ways in the hold vs sell discussion. Some see anchor participation as supportive for sentiment around listing. Others treat it as just one component, arguing that listing outcomes depend on broader market conditions and demand at the open. Either way, anchor allocation has become a frequent reference in IPO threads.

Grey market premium: the numbers being tracked

The unofficial GMP has been reported at multiple levels across the bidding window. One update pegged GMP at ₹165, implying an estimated listing price of around ₹650 versus the ₹485 upper band, or about 34% potential gain. Earlier and alternate updates cited GMP around ₹185 to ₹190, suggesting a 38% to 39% listing pop if sustained. Another frequently repeated figure was a GMP of ₹194 on July 22, described as roughly 40% of the upper price band and implying an estimated price of ₹679 if that premium holds. These calculations are central to the “sell on listing” argument because they frame a potential quick return. At the same time, commenters repeatedly flag that GMP is unofficial and can change quickly. The wide range of quoted GMP levels itself has become a cautionary signal for some investors.

Key IPO facts at a glance

The following table consolidates the most-shared facts and timelines from the circulating summaries. The dates are described as tentative and subject to revisions in the same sources.

Dates and mechanics: what happens between allotment and listing

With the subscription closing on July 27, investors are watching the end-of-issue subscription print closely. The basis of allotment is expected to be finalised on July 28. Refund initiation is listed for July 29 in the timeline being shared. Credit of shares to demat accounts is also shown as July 29. The listing is tentatively scheduled for July 30 on both NSE and BSE, subject to regulatory approvals and completion of formalities. This tight schedule matters for the sell vs hold discussion because the first tradable session arrives quickly after allotment. Investors also focus on the opening price discovery on listing day, which can be volatile. The timeline encourages some applicants to pre-plan their action for listing day rather than deciding in the moment.

Hold or sell on listing: a checklist investors are using

The most common “sell on listing” argument in online threads is simple: GMP implies a 34% to 40% pop, so booking profits reduces uncertainty. This view is often paired with the fact that the issue is heavily OFS, meaning the IPO largely facilitates exits by existing holders rather than raising large new capital. On the other side, the “hold” argument is often tied to the demand narrative, including full subscription on Day 1 and strong NII subscription in the Day 2 snapshot. Some investors also cite the disclosed anchor participation as a supportive sentiment cue. A balanced way to frame the decision, based only on shared facts, is to treat GMP as a sentiment indicator, not a promise. Another practical consideration is category-wise subscription: the shared Day 2 data showed QIB participation still low, while NII demand was high, and different investors weigh that differently. Finally, many posts remind readers that the listing price will be set by actual market orders on July 30, not by GMP calculations.